Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald L Yee

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Pediatric Blood & Cancer|May 8, 2014
Age-related differences in urinary 11-dehydroxythromboxane B2 between infants, children, and adolescents: another example of developmental hemostasis?Charles D Varnell, Stuart L Goldstein, Donald L Yee, et al.
Pediatric Blood & Cancer|May 19, 2017
Association of outcomes and anti-Xa levels in the treatment of pediatric venous thromboembolismJennifer L Fan, Laura E Roberts, Michael E Scheurer, et al.
Thrombosis and Haemostasis|March 13, 2019
PREVAPIX-ALL: Apixaban Compared to Standard of Care for Prevention of Venous Thrombosis in Paediatric Acute Lymphoblastic Leukaemia (ALL)-Rationale and DesignSarah H O'Brien, Danshi Li, Lesley G Mitchell, et al.
Thrombosis and Haemostasis|July 11, 2017
Safety and efficacy of a glycoPEGylated rFVIII (turoctocog alpha pegol, N8-GP) in paediatric patients with severe haemophilia ASandrine Meunier, Jayanthi Alamelu, Silke Ehrenforth, et al.
Annals of Vascular Surgery|April 5, 2014
Catheter-directed thrombolysis for severe pulmonary embolism in pediatric patientsAarti C Bavare, Swati X Naik, Peter H Lin, et al.
Journal of Pediatric and Adolescent Gynecology|October 19, 2016
Assessment of an Electronic Intervention in Young Women with Heavy Menstrual BleedingJennifer E Dietrich, Donald L Yee, Xiomara M Santos, et al.
The New England Journal of Medicine|April 8, 2026
A Phase 2 Randomized Trial of Mezagitamab in Primary Immune ThrombocytopeniaDavid J Kuter, Katsuhiro Miura, Andrea Patriarca, et al.
Journal of Pediatric Hematology/Oncology|November 5, 2015
Validation Study of the Composite Score to Identify Von Willebrand Disease in ChildrenLynn M Malec, Charity G Moore, Carolyn M Bennett, et al.
Blood Advances|February 5, 2025
Mosunetuzumab plus Pola-CHP compared with Pola-R-CHP in previously untreated DLBCL: final results from a phase 2 studyJason Westin, Tycel J Phillips, Amitkumar Mehta, et al.
Blood Advances|August 15, 2023
Mosunetuzumab in combination with CHOP in previously untreated DLBCL: safety and efficacy results from a phase 2 studyAdam J Olszewski, Tycel J Phillips, Marc S Hoffmann, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Pediatric Blood & Cancer|May 8, 2014
Age-related differences in urinary 11-dehydroxythromboxane B2 between infants, children, and adolescents: another example of developmental hemostasis?Charles D Varnell, Stuart L Goldstein, Donald L Yee, et al.
Pediatric Blood & Cancer|May 19, 2017
Association of outcomes and anti-Xa levels in the treatment of pediatric venous thromboembolismJennifer L Fan, Laura E Roberts, Michael E Scheurer, et al.
Thrombosis and Haemostasis|March 13, 2019
PREVAPIX-ALL: Apixaban Compared to Standard of Care for Prevention of Venous Thrombosis in Paediatric Acute Lymphoblastic Leukaemia (ALL)-Rationale and DesignSarah H O'Brien, Danshi Li, Lesley G Mitchell, et al.
Thrombosis and Haemostasis|July 11, 2017
Safety and efficacy of a glycoPEGylated rFVIII (turoctocog alpha pegol, N8-GP) in paediatric patients with severe haemophilia ASandrine Meunier, Jayanthi Alamelu, Silke Ehrenforth, et al.
Annals of Vascular Surgery|April 5, 2014
Catheter-directed thrombolysis for severe pulmonary embolism in pediatric patientsAarti C Bavare, Swati X Naik, Peter H Lin, et al.
Journal of Pediatric and Adolescent Gynecology|October 19, 2016
Assessment of an Electronic Intervention in Young Women with Heavy Menstrual BleedingJennifer E Dietrich, Donald L Yee, Xiomara M Santos, et al.
The New England Journal of Medicine|April 8, 2026
A Phase 2 Randomized Trial of Mezagitamab in Primary Immune ThrombocytopeniaDavid J Kuter, Katsuhiro Miura, Andrea Patriarca, et al.
Journal of Pediatric Hematology/Oncology|November 5, 2015
Validation Study of the Composite Score to Identify Von Willebrand Disease in ChildrenLynn M Malec, Charity G Moore, Carolyn M Bennett, et al.
Blood Advances|February 5, 2025
Mosunetuzumab plus Pola-CHP compared with Pola-R-CHP in previously untreated DLBCL: final results from a phase 2 studyJason Westin, Tycel J Phillips, Amitkumar Mehta, et al.
Blood Advances|August 15, 2023
Mosunetuzumab in combination with CHOP in previously untreated DLBCL: safety and efficacy results from a phase 2 studyAdam J Olszewski, Tycel J Phillips, Marc S Hoffmann, et al.
Pageof 5